InsidersTradesSigma
申报总数
公司
▲ 买入（6 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
6
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Wiggans Thomas G, 董事. Insider active across 4 companies, notably Forma Therapeutics Holdings, Inc.. Aggregated, 14 reports have been logged. Breakdown: 6 buys · 4 sells. Total volume traded: €140k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 22 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Wiggans Thomas G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
41,000 股@ US$2.4383.0% 占其流量Voting Common StockSEC:0001213900-25-091105:0
标准退出：2025年12月21日 (T+90)
10,000 股@ US$0.648634.3% 占其流量Voting Common StockSEC:0001213900-23-091458:0
标准退出：2024年2月26日 (T+90)
10,000 股@ US$0.638333.8% 占其流量Voting Common StockSEC:0001213900-23-089579:0
标准退出：2024年2月19日 (T+90)
10,000 股@ US$0.596531.9% 占其流量Voting Common StockSEC:0001213900-23-088896:0
标准退出：2024年2月14日 (T+90)
50,000 股Common StockSEC:0001209191-23-047836:0
12,500 股@ US$1.0934.1% 占其流量Common StockSEC:0001209191-22-060154:0
标准退出：2023年3月5日 (T+90)
25,000 股@ US$1.0465.9% 占其流量Common StockSEC:0001209191-22-059677:0
标准退出：2023年3月1日 (T+90)
7,250 股Common StockSEC:0000899243-22-033650:0
4,500 股0Common StockSEC:0000899243-22-021666:0
2,750 股0Common StockSEC:0000899243-21-025095:0
8,700 股Common StockSEC:0001562180-16-001471:0
300 股Common StockSEC:0001562180-16-001471:1
10,492 股Common StockSEC:0001562180-16-001270:0
508 股Common StockSEC:0001562180-16-001270:1
14 条申报中的 14 条
About Wiggans Thomas G
Thomas G. Wiggans is Administrateur and has 14 filings in total. Among the 14 sampled filings, all are buys for a total of EUR 139531, with no sells, and they span from 2016-01-06 to 2025-09-24. The recent filings relate to Jasper Therapeutics, Inc. and Pardes Biosciences, INC., with individual amounts of EUR 84424.471369359, EUR 24939.20052562364 and EUR 12921.81346878454 for Pardes Biosciences, INC., and EUR 5918.734507960324, EUR 5831.381428725613 and EUR 5495.375338134178 for Jasper Therapeutics, Inc.
